Fulgent Genetics Price to Book Ratio 2015-2024 | FLGT
Historical price to book ratio values for Fulgent Genetics (FLGT) over the last 10 years. The current price to book ratio for Fulgent Genetics as of December 02, 2024 is 0.49.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Fulgent Genetics Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-29 | 18.30 | 0.49 | |
| 2024-09-30 | 21.73 | $37.16 | 0.58 |
| 2024-06-30 | 19.62 | $37.30 | 0.53 |
| 2024-03-31 | 21.70 | $37.69 | 0.58 |
| 2023-12-31 | 28.91 | $38.22 | 0.76 |
| 2023-09-30 | 26.74 | $42.01 | 0.64 |
| 2023-06-30 | 37.03 | $42.23 | 0.88 |
| 2023-03-31 | 31.22 | $42.74 | 0.73 |
| 2022-12-31 | 29.78 | $43.14 | 0.69 |
| 2022-09-30 | 38.12 | $43.17 | 0.88 |
| 2022-06-30 | 54.53 | $43.31 | 1.26 |
| 2022-03-31 | 62.41 | $43.29 | 1.44 |
| 2021-12-31 | 100.59 | $38.66 | 2.60 |
| 2021-09-30 | 89.95 | $35.01 | 2.57 |
| 2021-06-30 | 92.23 | $31.20 | 2.96 |
| 2021-03-31 | 96.62 | $27.65 | 3.49 |
| 2020-12-31 | 52.10 | $20.21 | 2.58 |
| 2020-09-30 | 40.04 | $8.02 | 4.99 |
| 2020-06-30 | 16.00 | $3.99 | 4.01 |
| 2020-03-31 | 10.76 | $3.75 | 2.87 |
| 2019-12-31 | 12.90 | $3.85 | 3.35 |
| 2019-09-30 | 10.39 | $2.92 | 3.56 |
| 2019-06-30 | 6.68 | $2.78 | 2.40 |
| 2019-03-31 | 5.95 | $2.73 | 2.18 |
| 2018-12-31 | 3.17 | $2.81 | 1.13 |
| 2018-09-30 | 3.93 | $2.91 | 1.35 |
| 2018-06-30 | 4.14 | $2.93 | 1.41 |
| 2018-03-31 | 4.00 | $2.97 | 1.35 |
| 2017-12-31 | 4.38 | $3.04 | 1.44 |
| 2017-09-30 | 4.79 | $3.11 | 1.54 |
| 2017-06-30 | 6.39 | $3.14 | 2.03 |
| 2017-03-31 | 10.92 | $3.13 | 3.49 |
| 2016-12-31 | 11.57 | $3.08 | 3.75 |
| 2016-09-30 | 9.22 | $1.34 | 6.87 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.560B | $0.289B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.855B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.039B | 179.00 |
| Inspire Medical Systems (INSP) | United States | $5.776B | 180.15 |
| Enovis (ENOV) | United States | $2.727B | 18.49 |
| IRhythm Technologies (IRTC) | United States | $2.722B | 0.00 |
| Privia Health (PRVA) | United States | $2.578B | 214.80 |
| Omnicell (OMCL) | United States | $2.158B | 70.59 |
| Azenta (AZTA) | United States | $2.106B | 112.71 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.744B | 0.00 |
| Schrodinger (SDGR) | United States | $1.644B | 0.00 |
| Phreesia (PHR) | United States | $1.215B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
| Standard BioTools (LAB) | United States | $0.685B | 0.00 |
| Talkspace (TALK) | United States | $0.578B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.546B | 94.60 |
| Health Catalyst (HCAT) | United States | $0.537B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 78.04 |
| Pulmonx (LUNG) | United States | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.223B | 0.00 |
| American Well (AMWL) | United States | $0.147B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.109B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.082B | 0.00 |
| 111 (YI) | China | $0.071B | 0.00 |
| CareCloud (CCLD) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.047B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.037B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |